Unique ID issued by UMIN | UMIN000008101 |
---|---|
Receipt number | R000009534 |
Scientific Title | Antispastic efficasy of l-menthol spray on the duodenal mucosa compared with intravenous administration of scopolamine butylbromide for endoscopic retrograde cholangiopancreatography (ERCP) |
Date of disclosure of the study information | 2012/06/04 |
Last modified on | 2012/06/04 19:11:36 |
Antispastic efficasy of l-menthol spray on the duodenal mucosa compared with intravenous administration of scopolamine butylbromide for endoscopic retrograde cholangiopancreatography (ERCP)
Antispastic efficasy of l-menthol compared with scopolamine butylbromide for ERCP
Antispastic efficasy of l-menthol spray on the duodenal mucosa compared with intravenous administration of scopolamine butylbromide for endoscopic retrograde cholangiopancreatography (ERCP)
Antispastic efficasy of l-menthol compared with scopolamine butylbromide for ERCP
Japan |
biliary tract disease
Gastroenterology | Hepato-biliary-pancreatic medicine |
Others
NO
The aim of this study is to assess the duodenal antiperistaltic effect of 1.6% l-menthol spray on the duodenal mucosa compared with that of scopolamine butylbromide intravenous administration during endoscopic retrograde cholangiopancreatography.
Safety,Efficacy
The primary outcome was the rate of peristalsis suppression of duodenum after treatment.
Interventional
Parallel
Randomized
Open -no one is blinded
Active
2
Treatment
Medicine |
l-mentol spray on the duodenal mucosa during ERCP
scopolamine butylbromide intravenous administration during ERCP
20 | years-old | <= |
Not applicable |
Male and Female
The study group included patients who required cholangiography.
Patients who are planned ERCP. Patients or their family who fully understand and are willing to give a written informed consent about participation.
age 20 years younger; severe heart disease; severe lung disease; prostatic hyperplasia; glaucoma; contraindication to scopolamine butylbromide; pregnant and breast-feeding women or women suspected of being pregnant; women are not willing to avoid pregnancy during the duration of study; acute pancreatitis; chronic pancreatitis with an acute exacerbation; post gastrectomy; biliary cannulation using with Rendezvous method; contrast medium allergy; or refusal to provide informed consent.
200
1st name | |
Middle name | |
Last name | Kazuhiko Tokita |
Kyoto prefectural Yosanoumi hospital
Department of gastroenterology and hepatology
481 Otokoyama Yosano-cho, 629-2261 Japan
1st name | |
Middle name | |
Last name | Yasuyuki Gen |
Kyoto prefectural Yosanoumi hospital
Department of gastroenterology and hepatology
y-gen6-4@koto.kpu-m.ac.jp
Kyoto prefectural Yosanoumi hospital
Kyoto prefectural Yosanoumi hospital
Self funding
NO
2012 | Year | 06 | Month | 04 | Day |
Unpublished
Open public recruiting
2012 | Year | 04 | Month | 18 | Day |
2012 | Year | 05 | Month | 01 | Day |
2012 | Year | 06 | Month | 04 | Day |
2012 | Year | 06 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009534
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |